Chronic bronchitis: Should it worry us?

Chronic Respiratory Disease

Volumn 1, Issue 3, 2004, Pages 173-176

  Vestbo, J ^a  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

COPD; epidemiology; hospitalization; infection; mortality; mucus

Indexed keywords

CHRONIC BRONCHITIS; DISEASE COURSE; HEALTH; HUMAN; INCIDENCE; PROGNOSIS; REVIEW; SURVIVAL RATE;

BRONCHITIS, CHRONIC; DISEASE PROGRESSION; HUMANS; INCIDENCE; PROGNOSIS; SURVIVAL RATE; WORLD HEALTH;

EID: 33644628056     PISSN: 14799723     EISSN: None     Source Type: Journal    
DOI: 10.1191/1479972304cd022rs     Document Type: Review

References (45)

1. Ciba Guest Symposium. Terminology, definitions and classification of chronic pulmonary emphysema and related conditions. Thorax 1959; 14: 286-299.
2. Medical Research Council's committee on the aetiology of chronic bronchitis. Standardized questionnaires on respiratory symptoms. Br Med J 1960; 2: 1665-1665.
3. Medical Research Council. Instructions for the use of the questionnaire on respiratory symptoms. Devon: W.J. Holman Ltd., 1966.
4. Cochrane AL, Chapman PJ, Oldham PD. Observer's errors in taking medical histories. Lancet 1951; i: 1007-1009.
5. Fairbarn AS, Wood CH, Fletcher CM. Variability to answers to a questionnaire on respiratory symptoms. Br J Prev Soc Med 1959; 13: 175-193.
6. Fletcher CM, Tinker CM. Chronic bronchitis. A further study of simple diagnostic methods in a working population. Br Med J 1961; i: 1491-1498.
7. Lange P, Groth S, Nyboe J et al. Chronic obstructive lung disease in Copenhagen: cross-sectional epidemiological aspects. J Intern Med 1989; 226: 25-32.
8. Pride NB, Burrows B. Development of impaired lung function: natural history and risk factors. In Calverley P, Pride NB, eds Chronic Obstructive Pulmonary Disease. London: Chapman & Hall, 1995.
9. Fletcher CM, Peto R, Tinker C, Speizer FE. The natural history of chronic bronchitis and emphysema. Oxford: Oxford University Press, 1976.
10. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-1648.
11. Kauffmann F, Drouet D, Lellouch J, Brille D. Twelve years spirometric changes among Paris area workers. Int J Epidemiol 1979; 8: 201-212.
12. Higgins MW, Keller JB, Becker M et al. An index of risk for obstructive airways disease. Am Rev Respir Dis 1982; 125: 144-151.
13. Peto R, Speizer FE, Cochrane AL et al. The relevance in adults of airflow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis 1983; 128: 491-500.
14. Ebi-Kryston KL. Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall study. J Clin Epidemiol 1988; 41: 251-260.
15. Wiles FJ, Hnizdo E. Relevance of airflow obstruction and mucus hypersecretion to mortality. Respir Med 1991; 85: 27-35.
16. Annesi I, Kauffmann F. Is respiratory mucus hypersecretion really an innocent disorder? Am Rev Respir Dis 1986; 134: 688-693.
17. Vollmer WM, McCamant LE, Johnson LR, Buist AS. Respiratory symptoms, lung function, and mortality in a screening center cohort. Am J Epidemiol 1989; 129: 1157-1169.
18. Speizer FE, Fay ME, Dockery DW, Ferris BG Jr. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis 1989; 140 (Suppl): S49-S55.
19. Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990; 45: 579-585.
20. Sherman CB, Xu X, Speizer FE, Ferris Jr BG, Weiss ST, Dockery DW. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992; 146: 855-859.
21. Vestbo J, Prescott E, Lange P, and The Copenhagen City Heart Study Group. Association of chronic mucus hypersecretion with FEV1 decline and COPD morbidity. Am J Respir Crit Care Med 1996; 153: 1530-1535.
22. Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
23. Fabbri LM, Hurd S, for the GOLD Scientific Committee. Global strategy for diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003; 22: 1-2.
24. Vestbo J, Lange P Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002; 166: 329-332.
25. Kanner RE, Anthonisen NR, Connett JE for the Lung Health Study Research Group. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 358-364.
26. Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-852.
27. Patel IS, Seemungal TER, Wilks M, Lloyd-Owen J, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57: 759-764.
28. Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995; 8: 1333-1338.
29. Vestbo J, Rasmussen FV Respiratory symptoms and FEVy as predictors of hospitalization and medication in the following 12 years due to respiratory disease. Eur Respir J 1989; 2: 710-715.
30. Jedrychowski W Sickness absence caused by chest disease in relation to smoking and chronic bronchitis symptoms. Br J Ind Med 1976; 33: 243-248.
31. Fletcher CM. Chronic bronchitis. Its prevalence, nature, and pathogenesis. Am Rev Respir Dis 1959; 80: 483-494.
32. Ames RG, Trent RB. Respiratory impairment and symptoms as predictors of early retirement with disability in US underground coal miners. Am J Public Health 1984; 74: 837-838.
33. Vestbo J. Predictors of mortality, COPD morbidity, and cancer. With special reference to respiratory symptoms, lung function, and occupational exposure to cement dust. Dan Med Bull 1993; 40: 1-16.
34. Halbert RJ, Isonaka S, George D, Iqbal A. Interpreting COPD prevalence estimates. Chest 2003; 123: 1684-1692.
35. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol 2000; 53: 755-761.
36. Lange P, Parner J, Prescott, Vestbo J. Chronic bronchitis in an elderly population. Age Ageing 2003; 32: 636-642.
37. Lange P, Groth S, Nyboe J et al. Phlegm production in plain cigarette smokers who changed to filter cigarettes or quit smoking. J Intern Med 1990; 228: 115-120.
38. Lange P, Groth S, Nyboe J et al. Determinants of chronic mucus hypersecretion in a general population with special reference to the type of tobacco smoked. Int J Epidemiol 1989; 18: 882-887.
39. Haynes WJ, Krstulovic V, Bell AJ. Smoking habit and incidence of respiratory tract infections in a group of adolescent males. Am Rev Respir Dis 1966; 93: 730-735.
40. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalisation from pneumonia. A prospective study of a general population. Eur Respir J 1995; 8: 1694-1698.
41. Almirall J, Gonzalez C, Balanzo X, Bolibar I. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest 1999; 116: 375-379.
42. Godtfredsen NS, Vestbo J, Osler M, Prescott E. Risk of hospital admission for COPD following smoking cessation and reduction: a Danish Population study. Thorax 2002; 57: 967-972.
43. Godtfredsen NS, Holst C, Prescott E, Vestbo J, Petersen L, Osler M. Smoking reduction, smoking cessation, and all-cause mortality. A 16-year follow-up of 19,709 men and women from the Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 2002; 156: 994-1001.
44. Nicolson P, Anderson P Quality of life, distress and self-esteem: a focus group study of people with chronic bronchitis. Br J Health Psychol 2003; 8: 251-270.
45. Connolly MJ. Chronic bronchitis: an old man's enemy? Age Ageing 2003; 32: 561-562.